FiftyBidsGovernment contracts and grants, in one plain-English search.

Back to search

Forecast

Restoring Joint Health and Function to Reduce Pain (RE-JOIN) 2.0

The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), in conjunction with other NIH Institutes and Centers (ICs) as a part of the congressionally mandated NIH Helping to End Addiction Long Term (HEAL) initiative intends to publish a Notice of Funding Opportunity (NOFO) to leverage and…

FromNational Institutes of Health
Who can applystate governments, counties, cities and townships, special districts (water, fire, parks, etc.), school districts, public colleges and universities and 9 more types
Eligibility notesOther Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S.
How muchabout 8 awards
DeadlineTue, Dec 1, 2026 (estimated) (39 days left)
CategoryHealth
TypeCooperative agreement
Opportunity #RFA-AR-26-006
Assistance listing93.846
PostedThu, Jan 22, 2026

Heads-up: Forecast: not open yet. Dates and amounts are the agency's estimates.

Open the official posting

From the notice

The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), in conjunction with other NIH Institutes and Centers (ICs) as a part of the congressionally mandated NIH Helping to End Addiction Long Term (HEAL) initiative intends to publish a Notice of Funding Opportunity (NOFO) to leverage and accelerate the progress achieved in the Restoring Joint Health and Function to Reduce Pain (RE-JOIN) Consortium.The NOFO aims to more fully refine and map the innervation of the different articular and peri-articular tissues that collectively form the joint (including bone, cartilage, synovium, joint capsule, ligament, tendon, fascia and muscle), by sensory neurons that mediate the sensation of pain.The NOFO seeks to expand initial and ongoing efforts by:Enhancing clinical pain phenotyping with multimodal profiling of new and expanded patient samples across life span and disease conditions (i.e., other musculoskeletal and/or rheumatic conditions associated with joint pain beyond knee and temporomandibular joint (TMJ)).Expanding to new preclinical and New Approach Methodologies (NAMs) in modeling joint disease.Preclinical testing of novel joint-targeted candidates identified in RE-JOIN 1.0.Focusing on peri-articular tissues in joint pain, such as vasculature, synovium, adipose, myofascial tissue, etc.Prioritizing secondary analysis of datasets and/or validation of methods and approaches in human samples.Improve data integration by developing/enhancing joint atlases th

We may have shortened this. The official posting is the record. We are not affiliated with the agency that published it.